医药中间体是指在药物合成过程中作为关键步骤的反应产物或原料物质,它们通常是化学结构较为简单的化合物,通过一系列化学反应可以转化为最终的药物成品。这些中间体在制药工业中扮演着重要角色,是实现复杂药物分子合成的关键组成部分。
特点医药中间体的研发和生产是一个复杂的过程,通常包括以下几个步骤:
随着化学合成技术的进步和新技术的应用(如绿色化学、计算机辅助设计等),医药中间体的研发与生产正朝着更加高效、环保的方向发展。同时,对药物分子结构的深入理解也为开发更有效的治疗方案提供了更多可能性。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
1-(2-嘧啶基)哌啶-4-胺 | tert-butyl (1-(pyrimidin-2-yl)piperidin-4-yl)carbamate | 412355-81-8 | C9H14N4 |
|
1-(2-嘧啶基)哌啶-4-甲酸乙酯 | 1-pyrimidin-2-ylpiperidine-4-carboxylic acid ethyl ester | 111247-60-0 | C12H17N3O2 |
|
1-(2-嘧啶)哌啶-4-甲醇 | (1-(pyrimidin-2-yl)piperidin-4-yl)methanol | 111247-61-1 | C10H15N3O |
|
1-(2-呋喃甲酰基)哌嗪盐酸盐 | 1-<(2-Furanyl)carbonyl>piperazinhydrochlorid | 60548-09-6 | C9H12N2O2*ClH |
|
1-(2-吡嗪基)-4-哌啶甲酸 | 1-pyrazin-2-yl-piperidine-4-carboxylic acid | 606104-21-6 | C10H13N3O2 |
|
1-(2-吡啶基)环丙胺二盐酸盐 | 1-(2-Pyridyl)cyclopropylamine Dihydrochloride | 1215107-39-3 | C8H12Cl2N2 |
|
1-(2-吡啶基)哌嗪 | 1-(2-pyridyl)piperazine | 34803-66-2 | C9H13N3 |
|
1-(2-吡啶基)三氟乙胺 | α-(trifluoromethyl)-2-pyridinemethanamine | 503173-14-6 | C7H7F3N2 |
|
1-(2-吡啶基)-哌嗪酮 | 1-(pyridin-2-yl)piperazin-2-one | 345310-98-7 | C9H11N3O |
|
1-(2-二甲基氨基乙基)-1H-5-巯基-四氮唑 | 1-[2-(dimethylamino)ethyl]-1,2-dihydro-5H-tetrazole-5-thione | 61607-68-9 | C5H11N5S |
|
1-(2-乙氧基-乙基)-2-哌啶-4-基-1H-苯并咪唑 | 1-(2-ethoxyethyl)-2-(piperidin-4-yl)-1H-benzo[d]imidazole | 110963-63-8 | C16H23N3O |
|
1-(2-乙氧基-2-氧乙基)溴化吡啶 | N-(ethoxycarbonylmethyl)pyridinium bromide | 17282-40-5 | Br*C9H12NO2 |
|
1-(2-三氟甲基苯基)咪唑 | 1-(2-trifluoromethylphenyl)-imidazole | 25371-96-4 | C10H7F3N2 |
|
1-(2-三氟甲基苯基)吡唑-4-甲酸 | 1-(2-(trifluoromethyl)phenyl)-1H-pyrazole-4-carboxylic acid | 1260855-51-3 | C11H7F3N2O2 |
|
1-(2-(4-(氯甲基)苯氧基)乙基)氮杂烷盐酸盐 | 1-(2-(4-(chloromethyl)phenoxy)ethyl)azepane hydrochloride | 223251-25-0 | C15H22ClNO*ClH |
|
1-(2-(3-甲酰基-N-甲基苯甲酰氨基)乙基)哌啶-4-基[1,1'-联苯]-2-基氨基甲酸酯 | biphenyl-2-ylcarbamic acid 1-(2-[(4-formylbenzoyl)methylamino]ethyl)piperidin-4-yl ester | 864760-28-1 | C29H31N3O4 |
|
1-(2,6-二甲基苯氧基)-2-丙酮 | 1-(2,6-dimethylphenoxy)propan-2-one | 53012-41-2 | C11H14O2 |
|
1-(2,4-双(苄氧基)-3,6-二羟基苯基)乙酮 | 1-(2,4-Bis(benzyloxy)-3,6-dihydroxyphenyl)ethanone | 1083181-35-4 | C22H20O5 |
|
1-(2,4-二羟基苯基)-2-(4-羟基苯基)-乙酮 | 2,4,4'-trihydroxy deoxybenzoin | 17720-60-4 | C14H12O4 |
|
1-(2,4-二氯苯基)哌嗪 | 1-(2,4-Dichloro-benzyl)-piperazine hydrochloride | 6270-11-7 | C11H15Cl3N2 |
|
1-(2,4-二氯苯基)哌嗪 | 1-(2,4-dichlorobenzyl)piperazine | 51619-56-8 | C11H14Cl2N2 |
|
1-(2,4-二氟苯基)哌嗪 | 1-(2,4-difluoro-phenyl)piperazine | 115761-79-0 | C10H12F2N2 |
|
1-(2,4,6-三甲基苯)-1,3-丁烷二酮 | mesitoylacetone | 6450-57-3 | C13H16O2 |
|
1-(2,3-二甲基苯基)哌啶 | 1-(2,3-dimethylphenyl)piperazine | 1013-22-5 | C12H18N2 |
|
1-(2,3-二氯苯基)哌嗪 | 1-(2,3-dichlorophenyl)-piperazine hydrochloride | 119532-26-2 | C10H12Cl2N2*ClH |
|
1-(2,3-二氯苯基)哌嗪 | 1-(2,3-dichloro-phenyl)-piperazine | 41202-77-1 | C10H12Cl2N2 |
|
1-(2,3-二氢-8-羟基-1,4-苯并二氧杂环己-5-基)乙烷-1-酮 | 5-Hydroxy-8-acetyl-benzodioxan-1,4 | 6204-62-2 | C10H10O4 |
|
1-(2,2-二氟乙基)哌嗪 | 1-(2,2-difluoroethyl)piperazine | 767609-14-3 | C6H12F2N2 |
|
1-(2,2,2-三氟乙基)哌嗪二盐酸盐 | 1-(2,2,2-Trifluoroethyl)piperazine dihydrochloride | 13349-91-2 | C6H13Cl2F3N2 |
|
1-(2'-噻吩基)乙基硫醇 | 1-(thiophene-2-yl)ethanethiol | 94089-02-8 | C6H8S2 |
|
1-(1H-吲哚-3-基)-2-(吗啉-4-基)乙烷-1,2-二酮 | 1-(1H-indol-3-yl)-2-(morpholin-4-yl)ethane-1,2-dione | 5625-89-8 | C14H14N2O3 |
|
1-(1H-吡咯并[2,3-c]吡啶-3-基)乙酮 | 3-Acetyl-6-azaindol | 67058-71-3 | C9H8N2O |
|
1-(1H-吡咯并[2,3-B]吡啶-5-基)乙酮 | 1-(1H-pyrrolo[2,3-b]pyridin-5-yl)ethanone | 944937-14-8 | C9H8N2O |
|
1-(1-金刚烷基)溴化吡啶 | 1-(adamantan-1-yl)pyridinium bromide | 19984-57-7 | Br*C15H20N |
|
1-(1-萘甲基)哌嗪 | 1-naphthalen-1-ylmethyl-piperazine | 40675-81-8 | C15H18N2 |
|
1-(1-萘基)丙烯-1-酮 | 1-(naphthalen-1-yl)prop-2-en-1-one | 22422-69-1 | C13H10O |
|
1-(1-甲基哌啶-4-基)哌嗪三盐酸盐 | 1-(1-methylpiperidin-4-yl)piperazine hydrochloride | 349535-15-5 | C10H21N3*ClH |
|
1-(1-甲基哌啶-4-基)哌嗪 | 1-(1-methyl-piperidin-4-yl)-piperazine | 23995-88-2 | C10H21N3 |
|
1-(1-甲基-1H-咪唑-2-基)乙酮 | 2-acetyl-1-methylimidazole | 85692-37-1 | C6H8N2O |
|
1-(1-环己烯基)哌啶 | 1-(cyclohex-1-en-1-yl)piperidine | 2981-10-4 | C11H19N |
|
1-(1-氧化吡啶-3-基)乙酮 | 3-acetylpyridine N-oxide | 14188-94-4 | C7H7NO2 |
|
1-(1-氧代丙氧基)-2,5-吡咯烷二酮 | succinimidyl propionate | 30364-55-7 | C7H9NO4 |
|
1-(1-乙氧基乙基)-4-吡唑硼酸频哪醇酯 | 1-(1-ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole | 1029716-44-6 | C13H23BN2O3 |
|
1-(1-(3-甲氧基-4-硝基苯基)哌啶-4-基)-4-甲基哌嗪 | 1-(1-(3-methoxy-4-nitrophenyl)piperidin-4-yl)-4-methylpiperazine | 761440-65-7 | C17H26N4O3 |
|
1-((苄氧基)羰基)-3-苯基吡咯烷-3-羧酸 | 1-((benzyloxy)carbonyl)-3-phenylpyrrolidine-3-carboxylic acid | 871926-95-3 | C19H19NO4 |
|
1-((吡啶-4-基)甲基-4-哌啶酮 | 1-(4-pyridylmethyl)piperidin-4-one | 126832-82-4 | C11H14N2O |
|
1-((吡啶-4-基)甲基)哌啶-4-甲酸乙酯 | 1-Pyridin-4-ylmethylpiperidine-4-carboxylic acid ethyl ester | 138030-54-3 | C14H20N2O2 |
|
1-((4'-氯-5,5-二甲基-3,4,5,6-四氢-[1,1'-二苯基]-2-基)甲基)哌嗪 | 1-((4'-chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-yl)methyl)piperazine | 1228780-72-0 | C19H27ClN2 |
|
1-(((2R,3S),2-(2,4-二氟苯基)-3-甲基环氧乙烷-2-基)甲基)-1H-1,2,4-三唑 | 1-(((2R,3S)-2-(2,4-difluorophenyl)-3-methyloxiran-2-yl)-methyl)-1H-1,2,4-triazole | 127000-90-2 | C12H11F2N3O |
|
1,8-萘磺酸内酯 | 1,8-naphthosultone | 83-31-8 | C10H6O3S |
|